drugset / Trial / NCT00826514
An Efficacy And Safety Study Of Tanezumab For The Treatment Of Pain Associated With Chronic Abacterial Prostatitis
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to determine whether tanezumab is effective in the treatment of pain associated with chronic prostatitis.
Timeline
- Start
- 2009-03-25
- Primary completion
- 2010-01-11
- Completion
- 2010-03-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tanezumab | Monoclonal antibody | 20 mg | Intravenous |